Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI ranks Agilon Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Agilon Health, Inc. is a small-cap company with a market capitalization of $1.43B. It ranks number 5 by market capitalization among the 13 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast. Its D/E Ratio of 5.99x is the highest of the 10 peers that report one.
For AGL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 1.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, AGL included.
Follow AGL free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
| Metric | AGL | Rank |
|---|---|---|
| Market Cap | $1.43B | 5/13 |
| P/B Ratio | 6.28x | 2/9 |
| EPS | $-14.27 | – |
| Book Value/Share | $13.55 | – |
| Revenue/Share | $352.57 | – |
| FCF/Share | $-5.06 | – |
| Metric | AGL | Rank |
|---|---|---|
| ROE | -102.1% | 6/7 |
| ROA | -14.6% | 7/9 |
| ROIC | -110.9% | 7/8 |
| Operating Margin | -5.2% | 6/9 |
| Net Margin | -3.9% | 7/10 |
| EBT Margin | -4.3% | 6/10 |
| Tax Rate | -0.3% | – |
| Metric | AGL | Rank |
|---|---|---|
| Current Ratio | 1.08x | 8/11 |
| D/E Ratio | 5.99x | 1/10 |
| Financial Leverage | 6.99x | 1/9 |
| Interest Coverage | 5.7x | 5/12 |
| Working Capital | $106M | 4/11 |
| Metric | AGL | Rank |
|---|---|---|
| Operating Cash Flow | -$72M | 10/10 |
| Free Cash Flow | -$85M | 7/7 |
| Capital Spending | -$13M | 3/7 |
| FCF/Sales | -1.4% | 7/7 |
| CapEx/Sales | 0.2% | 7/7 |
| Metric | AGL | Rank |
|---|---|---|
| Asset Turnover | 3.72x | 1/9 |
| Receivables Turnover | 5.6x | 6/9 |
| Fixed Assets Turnover | 241.5x | 1/8 |
| Days Sales Outstanding | 65 days | 4/9 |
| Metric | AGL | Rank |
|---|---|---|
| Total Revenue | $5.92B | 3/10 |
| Operating Income | -$309M | 9/9 |
| Net Income | -$232M | 10/10 |
| Metric | AGL | Rank |
|---|---|---|
| Shares Outstanding | 17M | – |
| Total Current Assets | $1.42B | 89.1% of assets |
| Cash & Short-term Investments | $107M | 6.7% of assets |
| Accounts Receivable | $1.06B | 66.6% of assets |
| Total Liabilities | $1.36B | 85.7% of assets |
Companies classified under the same SEC industry code as Agilon Health, Inc. (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| AGL Agilon Health, Inc. | ▲ | $1.43B |
| FMS Fresenius Medical Care Ag | ▼ | $12.85B |
| DVA Davita Inc. | ▶ | $11.95B |
| SHC Sotera Health Co | ▼ | $5.11B |
| PGNY Progyny, Inc. | ▼ | $2.06B |
| VMD Viemed Healthcare, Inc. | ▼ | $361M |
| PARK Park Dental Partners, Inc. | ▲ | $91M |
| MRAI Marpai, Inc. | ▶ | $85M |
| CCEL Cryo Cell International Inc | ▲ | $29M |
| PFHO Pacific Health Care Organization Inc | ▲ | $12M |
| MGRX Mangoceuticals, Inc. | ▲ | $7M |
| NIVF Newgenivf Group Ltd | ▼ | $2M |
| BRTX Biorestorative Therapies, Inc. | ▶ | $2M |
AGL investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false ...
Thank you, operator. Good afternoon, and welcome to the call. With me are Executive Chairman, Ron Williams; and our CFO, Jeff Schwaneke. Following our prepared remarks, we will conduct a Q&A session.
Hello, and welcome to the agilon health Fourth Quarter 2025 Earnings Conference Call. My name is Carla, and I will be coordinating your call today. Thank you, operator. Good afternoon, and welcome to ...
Our AI ranks Agilon Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For AGL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 0.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 1.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Agilon Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
13 issuers in our coverage, AGL included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Fresenius Medical Care Ag (FMS), Davita Inc. (DVA), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Viemed Healthcare, Inc. (VMD), Park Dental Partners, Inc. (PARK).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.